scholarly journals Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor

2016 ◽  
pp. 1511 ◽  
Author(s):  
Chih-Jen Yang ◽  
Ming-Ju Tsai ◽  
Jen-Yu Hung ◽  
Ying-Ming Tsai ◽  
Jui-Ying Lee ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Stage Iv

Tyrosine kinase inhibitor (TKI) treatment outcome of stage IV-C thyroid differentiated cancer (analyzed by lesion evaluation)

2018 ◽  
Author(s):  
Hiroyuki Iwasaki ◽  
Haruhiko Yamazaki ◽  
Nobuyasu Suganuma ◽  
Yuko Sugawara ◽  
Naoki Gotoh ◽  
...  
Keyword(s):  
Treatment Outcome ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Stage Iv ◽  
Tki Treatment

scholarly journals Direct activation of PP2A for the treatment of tyrosine kinase inhibitor–resistant lung adenocarcinoma

JCI Insight ◽  
2019 ◽  
Vol 4 (4) ◽  
Author(s):  
Rita Tohmé ◽  
Sudeh Izadmehr ◽  
Sai Gandhe ◽  
Giancarlo Tabaro ◽  
Sanjay Vallabhaneni ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Direct Activation
Sign in / Sign up

Export Citation Format

Share Document